# A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring

Study · id `cardio:ct-nct05911256` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05911256](<https://clinicaltrials.gov/study/NCT05911256>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05911256

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 318 participants.

## Technical summary

Registry record NCT05911256. Randomized; double masking; primary purpose treatment. Start 2024-09-27 (actual); primary completion 2028-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 318 participants (planned count; ClinicalTrials.gov record NCT05911256, source copy `cardio:ctgov-nct05911256-2026-09-04`, retrieved 2026-10-26)
- Started: 2024-09-27 (actual) (ClinicalTrials.gov record NCT05911256, source copy `cardio:ctgov-nct05911256-2026-09-04`, retrieved 2026-10-26)
- Primary completion: 2028-03 (anticipated) (ClinicalTrials.gov record NCT05911256, source copy `cardio:ctgov-nct05911256-2026-09-04`, retrieved 2026-10-26)
- Completion: 2028-03 (anticipated) (ClinicalTrials.gov record NCT05911256, source copy `cardio:ctgov-nct05911256-2026-09-04`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05911256, source copy `cardio:ctgov-nct05911256-2026-09-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05911256-2026-09-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Community Health Worker/Pharmacist Team to Improve Blood Sugars in Diabetes Care Using Continuous Glucose Monitoring
- Acronym: TEAM-CGM
- Condition: Type 2 Diabetes
- Intervention (Behavioral): Pharmacist Only
- Intervention (Device): Continuous Glucose Monitor (CGM)
- Intervention (Behavioral): Community Health Worker (CHW)
- Lead sponsor: University of Massachusetts, Worcester
- Lead sponsor class: OTHER
- Collaborator: Baystate Health
- Collaborator class: OTHER
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: University of Massachusetts, Worcester (`cardio:org-university-of-massachusetts-worcester`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)

## Provenance

Content hash: 3f39f09688092a0687eb123f09a4f0ba445b50d2bc912fea918293c566287ec6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
